Search Results
Development of long-acting interferon as new therapy for PV and ET
Long-acting interferon: What is the difference?
Update on Long-acting Interferons for MPN
Update on Long-acting Interferons for MPN
Indication for cytoreductive therapy in ET and PV: Do we have it right?
Current therapy options and clinical outcomes analysis in patients with PV
Management of PV, the role of interferon
The role of interferon in PV
PROUD-PV/CONTINUATION-PV studies: benefits of ropeg IFN alfa-2b for the treatment of PV
Comparing Hydroxyurea and Pegylated Interferon-Alpha-2a in PV and ET
Conversation with an MPN Specialist: Summer Updates
Interferons and Myeloproliferative Neoplasms (MPNs)
